Interruption of Leprosy Treatment in Brazil
Author Information
Author(s): Heukelbach Jorg, Chichava Olga, de Oliveira Alexcian Rodrigues, Häfner Kathrin, Walther Friederike, de Alencar Carlos Henrique Morais, Ramos Alberto Novaes Jr., Ferreira Adriana Cavalcante, Ariza Liana
Primary Institution: Department of Community Health, School of Medicine, Federal University of Ceará, Fortaleza, Brazil
Hypothesis
What factors contribute to the interruption and defaulting of multidrug therapy against leprosy in Brazil?
Conclusion
Defaulting and interruption of multidrug therapy are linked to poverty-related factors and issues with drug supply.
Supporting Evidence
- 3% of patients defaulted on treatment.
- 18.2% of patients interrupted their multidrug therapy.
- Low family income was significantly associated with defaulting.
- Temporal non-availability of MDT drugs was a risk factor for treatment interruption.
Takeaway
Some people with leprosy stop taking their medicine because they move homes or have low income, and sometimes the medicine isn't available.
Methodology
A population-based study using structured questionnaires in 78 municipalities in Tocantins, Brazil.
Potential Biases
Non-participation bias may have affected the results, particularly among those who defaulted treatment.
Limitations
The low number of defaulters limited statistical analysis, and there were issues with incomplete patient records.
Participant Demographics
The study included 936 individuals, with a mean age of 42.1 years, and 52.5% were male.
Statistical Information
P-Value
p<0.03
Confidence Interval
0.80–0.99
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website